Filing Details

Accession Number:
0000899243-20-018261
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-02 16:05:04
Reporting Period:
2020-06-30
Accepted Time:
2020-07-02 16:05:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1805890 Fusion Pharmaceuticals Inc. FUSN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1449753 J James O'leary C/O Fusion Pharmaceuticals Inc.
270 Longwood Road South
Hamilton A6 L8P 0A6
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-30 300 $17.00 300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct